Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes. These inhibitors function by increasing incretin levels which in turn increases insulin secretion, thus decreasing blood glucose levels.
Type 2 diabetes (T2D) is a chronic disease that affects body™s blood sugar level. Elevated blood sugar level (hyperglycemia) causes detrimental effects on heart, kidneys, eyes, blood vessels, and nerves.Â
The four stages of manufacturing evolution have led us to Pharma 4.0. The phrase "Industries 4.0" was coined by the German federal government as part of a national ...
